Cargando…
Lidocaine patch (5%) is no more potent than placebo in treating chronic back pain when tested in a randomised double blind placebo controlled brain imaging study
BACKGROUND: The 5% Lidocaine patch is used for treating chronic neuropathic pain conditions such as chronic back pain (CBP), diabetic neuropathy and complex regional pain syndrome, but is effective in a variable proportion of patients. Our lab has reported that this treatment reduces CBP intensity a...
Autores principales: | Hashmi, Javeria A, Baliki, Marwan N, Huang, Lejian, Parks, Elle L, Chanda, Mona L, Schnitzer, Thomas, Apkarian, A Vania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3475108/ https://www.ncbi.nlm.nih.gov/pubmed/22531485 http://dx.doi.org/10.1186/1744-8069-8-29 |
Ejemplares similares
-
Brain Connectivity Predicts Placebo Response across Chronic Pain Clinical Trials
por: Tétreault, Pascal, et al.
Publicado: (2016) -
Corticostriatal functional connectivity predicts transition to chronic back pain
por: Baliki, Marwan N., et al.
Publicado: (2012) -
Risky monetary behavior in chronic back pain is associated with altered modular connectivity of the nucleus accumbens
por: Berger, Sara E, et al.
Publicado: (2014) -
Predictive Dynamics of Human Pain Perception
por: Cecchi, Guillermo A., et al.
Publicado: (2012) -
A preliminary fMRI study of analgesic treatment in chronic back pain and knee osteoarthritis
por: Baliki, Marwan N, et al.
Publicado: (2008)